Tier 1 CDMO and China's largest CXO with 32,000L solid-phase synthesis reactors across Changzhou and Taixing facilities. Major GLP-1 API manufacturing capabilities with massive global client base.
WuXi AppTec (Peptide Division) is based in Shanghai / Changzhou, China, specialising in CDMO, GLP-1 APIs, Solid-Phase Synthesis, Commercial Scale, minimum order Contract-based.
No manufacturing licence is recorded for WuXi AppTec (Peptide Division) in our data. That is an absence of information rather than evidence of a problem, but it means nothing here has been verified against a regulator's register.
No independent assay in our records names WuXi AppTec (Peptide Division) as the manufacturer. Manufacturer attribution only appears where a certificate of analysis records it, so this is common and is not a quality signal in itself.
Manufacturer entries describe who produces a compound, not who sells it to you. For purchasing, the vendor directory records storefront reachability, assay history and FDA warning-letter history separately.
Directories: All manufacturers, Vendor directory, Independent lab tests.